Polynovo (FRA:MFJ) Total Stockholders Equity : €45.66 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Polynovo Total Stockholders Equity?

Polynovo's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €45.66 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Polynovo's Book Value per Share for the quarter that ended in Dec. 2024 was €0.07. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Polynovo's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.23.

Polynovo Total Stockholders Equity Historical Data

The historical data trend for Polynovo's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo Total Stockholders Equity Chart

Polynovo Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Stockholders Equity

Get a 7-Day Free Trial

14.59

14.18

11.78

40.50

44.49

Polynovo Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															40.06	40.50	42.38	44.49	45.66

Polynovo (FRA:MFJ) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Polynovo's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(45.66	-	0)	/	690.843
	=	0.07

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Polynovo's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.354	+	8.082)	/	45.66
	=	0.23

Polynovo Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Polynovo's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Polynovo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (FRA:MFJ) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

CALZF:USA PNV:Australia

Address

320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207

Website

https://www.polynovo.com

Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

Polynovo Headlines

No Headlines